Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CEP-33779 is a potent, orally available inhibitor of JAK2 (IC50 = 1.3 nM).1 It shows 65-fold selectivity for JAK2 over JAK3.1 In mouse models of systemic lupus erythematosus, CEP-33779 reduces the production of inflammatory cytokines, decreases splenomegaly and lymphomegaly, and extends survival.1 It also diminishes inflammatory signaling and improves clinical scores in mice during collagen antibody-induced arthritis and collagen type II-induced arthritis.2 CEP-33779 induces regression of established colorectal tumors in mice, reducing angiogenesis and proliferation of tumor cells.3
WARNING This product is not for human or veterinary use.
1. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-
2. A highly selective, orally active inhibitor of Janus kinase 2, CEP-
3. Therapeutic efficacy of CEP-